Faculty

Institution

Unit

Venue

Michael Jelinek

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMichael Jelinek is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Jelinek

Rush University

You can click a keyword to filter the displayed items

oncology radiation oncology cancer treatment neck oncology cancer research cancer care pharmacology thoracic oncology pathology clinical trials lung cancer pharmacotherapy surgical oncology clinical radiation oncology neck cancer clinical research oncogenes oral pathology radiation therapy cancer management epidemiology tumor biology neuro-oncology molecular cancer cancer cells experimental medicine drug trials anti-cancer agents oral cancer stereotactic body radiotherapy carcinogenesis medicinal research cancer discovery cellular therapy cancer biology head trauma rehabilitation vascular biology jama oncology enzyme inhibition cohort studies environmental epidemiology case studies benchmark studies clinical mycology melanoma skin cancer tumor targeting preclinical drug evaluation extracellular microvesicles otorhinolaryngology larynx voice surgery epidemiology of cancer multiple pulmonary nodule bronchial neoplasm oral cavity treatment options systemic treatment treatment development sclerostin biomedical research ct scan egfr-directed therapy current state response-stratified chemoradiation therapy hpv-negative head elderly patients polymerase inhibitor veliparib representative ecological study increased incidence-rate depend trial response-stratified chemoradiation neoadjuvant nivolumab neck mucosal melanoma adjuvant osimertinib crki-containing microvesicles

Notable Scholarly Works

Notable Federal Grants

Collaborators

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in Hpv-Negative Head and Neck Cancer. JAMA Oncology (2025)

Ari J. RosenbergAditya JulooriMichael J. JelinekNishant AgrawalJohn F. CursioNicole CiprianiMark W. LingenEvgeny IzumchenkoRohan KatipallyJeffrey ChinDaniel GinatOlga Pasternak-WiseZhen GooiElizabeth BlairAlexander T. PearsonDaniel J. HarafEverett E. Vokes

radiation therapyneck cancerhead trauma rehabilitationneurovirologytumor biologycancer researchoncologycohort studiesneck oncologycancer treatmentneurologyresponse-stratified chemoradiation therapyradiation oncologyneuro-oncologyvascular biologyhpv-negative headradiologyjama oncologysurgical oncologyclinical radiation oncologythoracic oncology

State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer. Advances in Oncology (2025)

oral pathologysurgical oncologyoncologyradiation oncologycancer researchsurgeryneck oncologyneck pathologycancer careneck cancerart therapyadvanced head

Supplementary Data 1 From Interlink-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. (2025)

metastasisoncologyradiation oncologymolecular cancerneck oncologyrecurrent/metastatic headoncogenescancer treatmentsupplementary data 1phase iiimalignant diseasepathology

Using Liquid Biopsies to Guide Treatment and Monitor Response in Braf V600E Positive Adenocarcinoma of Unknown Primary. BMJ Case Reports (2025)

liquid biopsiesmonitor responseoncologyradiation oncologycancer researchunknown primarycancer cellssurgical pathologymalignant diseasemolecular pathologycancer detectionpathology

Air Pollution is Associated With Increased Incidence-Rate of Head and Neck Cancers: A Nationally Representative Ecological Study. Oral Oncology (2024)

Henrique Ochoa ScussiattoKerstin M. StensonSamer Al-KhudariMichael J. JelinekJayant M. PintoMihir K. Bhayani

environmental healthoncologypublic healthrepresentative ecological studyenvironmental epidemiologyair pollutionhealth sciencesepidemiologyincreased incidence-rate

Off the Top of Our Head. International Journal of Radiation Oncology*Biology*Physics (2024)

Radiation Therapy in the Management of Head and Neck Mucosal Melanoma. Cancers (2024)

oral pathologyradiation therapyoncologyradiation oncologyneck oncologydermatologyneuro-oncologyclinical radiation oncologyneck mucosal melanomamelanomaskin cancer

A Nationwide Analysis of Salvage Surgery for Laryngeal Cancer in the Elderly. Head & Neck (2023)

otorhinolaryngologysurgical oncologylarynxoncologyradiation oncologysurgeryneck oncologysalvage surgerylaryngeal canceroutcomes researchclinical otolaryngologyvoice surgeryfacial plastic surgerynationwide analysis

A Novel Immobilization Method for the Treatment of Head and Neck Cancer Using 3D Printing. Practical Radiation Oncology (2023)

novel immobilization methodadditive manufacturingradiation oncology3d printingbiomedical engineeringneck cancer3d bioprintingcontrolled releasebiomaterials

Association of Molecular Profiles of Head and Neck Squamous Cell Carcinoma With Heterogeneity Across Racial/Ethnic Groups in the United States.. Journal of Clinical Oncology (2023)

oral pathologytumor biologymolecular diagnosticscancer researchoncologymolecular cancerneck oncologydermatologyunited statesmolecular profilesoncogenescancer discoveryracial/ethnic groupshuman geneticsepidemiology of cancercarcinogenesispathology

1
2
3
4
10 / page

Michael Jelinek

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMichael Jelinek is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Jelinek

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in Hpv-Negative Head and Neck Cancer. JAMA Oncology (2025)

State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer. Advances in Oncology (2025)

oral pathologysurgical oncologyoncologyradiation oncologycancer researchsurgeryneck oncologyneck pathologycancer careneck cancerart therapyadvanced head

Supplementary Data 1 From Interlink-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. (2025)

metastasisoncologyradiation oncologymolecular cancerneck oncologyrecurrent/metastatic headoncogenescancer treatmentsupplementary data 1phase iiimalignant diseasepathology

Using Liquid Biopsies to Guide Treatment and Monitor Response in Braf V600E Positive Adenocarcinoma of Unknown Primary. BMJ Case Reports (2025)

liquid biopsiesmonitor responseoncologyradiation oncologycancer researchunknown primarycancer cellssurgical pathologymalignant diseasemolecular pathologycancer detectionpathology

Air Pollution is Associated With Increased Incidence-Rate of Head and Neck Cancers: A Nationally Representative Ecological Study. Oral Oncology (2024)

Henrique Ochoa ScussiattoKerstin M. StensonSamer Al-KhudariMichael J. JelinekJayant M. PintoMihir K. Bhayani

environmental healthoncologypublic healthrepresentative ecological studyenvironmental epidemiologyair pollutionhealth sciencesepidemiologyincreased incidence-rate

Off the Top of Our Head. International Journal of Radiation Oncology*Biology*Physics (2024)

Radiation Therapy in the Management of Head and Neck Mucosal Melanoma. Cancers (2024)

oral pathologyradiation therapyoncologyradiation oncologyneck oncologydermatologyneuro-oncologyclinical radiation oncologyneck mucosal melanomamelanomaskin cancer

A Nationwide Analysis of Salvage Surgery for Laryngeal Cancer in the Elderly. Head & Neck (2023)

A Novel Immobilization Method for the Treatment of Head and Neck Cancer Using 3D Printing. Practical Radiation Oncology (2023)

novel immobilization methodadditive manufacturingradiation oncology3d printingbiomedical engineeringneck cancer3d bioprintingcontrolled releasebiomaterials

Association of Molecular Profiles of Head and Neck Squamous Cell Carcinoma With Heterogeneity Across Racial/Ethnic Groups in the United States.. Journal of Clinical Oncology (2023)

1
2
3
4
10 / page